Redcare Pharmacy NV's ROE % for the quarter that ended in Mar. 2026 was -9.12%. Redcare Pharmacy NV's PB Ratio for the quarter that ended in Mar. 2026 was 1.46.
Redcare Pharmacy NV's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was -6.25%.
Redcare Pharmacy NV ROE % Adjusted to Book Value Related Terms
Redcare Pharmacy NV ROE % Adjusted to Book Value Historical Data
* Premium members only.
The historical data trend for Redcare Pharmacy NV's ROE % Adjusted to Book Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Redcare Pharmacy NV ROE % Adjusted to Book Value Chart
Redcare Pharmacy NV ROE % Adjusted to Book Value Competitor Comparison
For the Pharmaceutical Retailers subindustry, Redcare Pharmacy NV's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Redcare Pharmacy NV ROE % Adjusted to Book Value vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Redcare Pharmacy NV's ROE % Adjusted to Book Value distribution charts can be found below:
* The bar in red indicates where Redcare Pharmacy NV's ROE % Adjusted to Book Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROE % Adjusted to Book Value of -6.25% mean?
Redcare Pharmacy NV (XSWX:RDC) has a ROE % Adjusted to Book Value of -6.25% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Redcare Pharmacy NV and its competitors.
Is Redcare Pharmacy NV's ROE % Adjusted to Book Value too high?
Redcare Pharmacy NV's current ROE % Adjusted to Book Value is -6.25%. Overall, Redcare Pharmacy NV has a GF Score™ of 48/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Redcare Pharmacy NV's ROE % Adjusted to Book Value compare to competitors?
Redcare Pharmacy NV's ROE % Adjusted to Book Value of -6.25% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Healthcare Providers & Services company?
A good ROE % Adjusted to Book Value depends on the Healthcare Providers & Services industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Redcare Pharmacy NV and its competitors. Redcare Pharmacy NV's current ROE % Adjusted to Book Value is -6.25%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Redcare Pharmacy NV stock overvalued right now?
Based on GuruFocus' analysis, Redcare Pharmacy NV (XSWX:RDC) is currently considered Significantly Undervalued. The stock's GF Value™ is CHF143.20, compared to a current price of CHF60.95 — trading 57.4% below its estimated fair value. The current ROE % Adjusted to Book Value is -6.25%. Redcare Pharmacy NV's overall GF Score™ is 48/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Redcare Pharmacy NV (XSWX:RDC), the current ROE % Adjusted to Book Value is -6.25% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Redcare Pharmacy NV (XSWX:RDC) Overvalued in 2026?
Based on GuruFocus' analysis, Redcare Pharmacy NV stock appears to be undervalued.
The current stock price of CHF60.95 is trading 57.4% below its estimated GF Value™ of CHF143.20.
GuruFocus considers Redcare Pharmacy NV to be Significantly Undervalued.
Key valuation signals for XSWX:RDC:
ROE % Adjusted to Book Value: -6.25%
GF Value™: CHF143.20 vs. price of CHF60.95 (57.4% below fair value)
No single metric tells the full story. See the XSWX:RDC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Redcare Pharmacy NV is an online pharmacy business for prescription and nonprescription (over-the-counter) pharmaceuticals, beauty and personal care products (BPC) and food supplements. Besides OTC, nutritional supplements, beauty and personal care products as well as an extensive assortment of health-related products in all markets, the company also provides prescription drugs for customers in Germany, Switzerland and the Netherlands. It operates in two segments, namely DACH segment that includes sales in Germany, Austria and Switzerland; and the International segment that includes sales across Belgium, the Netherlands, France and Italy. The DACH segment accounts for the majority of the revenue.
48GF Score
Get the complete analysis for XSWX:RDC
ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:RDC has been successfully added to your 
